Saxagliptin

Especificaciones

361442-04-8Número CAS

111-193-7Número CE

(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrileNombre IUPAC

C18H25N3O2Fórmula química

315.4 g/molPeso molecular

Saxagliptin; 361442-04-8; BMS-477118; Saxagliptin anhydrous; BMS 477118; Saxagliptine; DTXSID7048580; 8I7IO46IVQ; DTXCID3028506; BMS477118; CHEBI:71272; Saxagliptina; NSC760407; (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; NSC-760407; (1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 3-hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate; QTERNMET COMPONENT SAXAGLIPTIN; saxagliptinum; (1S,3S,5S)-2-((2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile; (1S,3S,5S)-2-((2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile; RefChem:931331; A10BH03; (1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl) acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile hydrate; 9GB927LAJW; BMS-477118-11; Saxagliptin Monohydrate; Onglyza; Saxagliptin [INN]; OPC-262; CHEMBL385517; UNII-8I7IO46IVQ; Saxagliptin?; HSDB 8199; OPC 262; NCGC00242597-01; SAXAGLIPTIN [MI]; Saxagliptin (USAN/INN); SCHEMBL17168; SAXAGLIPTIN [WHO-DD]; MLS006011223; GTPL6316; BDBM11542; QGJUIPDUBHWZPV-SGTAVMJGSA-N; HMS3264P11; Pharmakon1600-01502500; MSK10924; SBMS-477118; Tox21_112908; BDBM50225074; EBC-02059; s1540; Saxagliptin (BMS-477118,Onglyza); AKOS015896547; Saxagliptin for system suitability CRS; AC-6008; CCG-213084; CCG-267647; CS-0650; DB06335; EX-7795; FA29598; NCGC00242597-02; NCGC00242597-08; NCGC00242597-10; HY-10285; SMR004702984; SY022234; CAS-361442-04-8; D08996; EN300-761487; AB01562984_01; AB01562984_02; Q3121121; BRD-A81513827-001-03-6; Z2235802036; (S)-3-Hydroxyadamantylglycine-L-cis-4,5-methanoprolinenitrile TFA salt; (1S,6S)-2-(2-adamantan-1-yl-2-amino-acetyl)-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile; (1S,3S,5S)-2-((2S)-AMINO(3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)ACETYL)-2-AZABICYCLO(3.1.0)HEXANE-3-CARBONITRILE; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2,2,2-trifluoroacetic acid; (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-oxoethyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; (1S,3S,5S)-2-[(S)-2-amino-2-(3-hydroxy-adamantan-1-yl)-acetyl]-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile; (1S,3S,5S)-2-[2-Amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-AZABICYCLO(3.1.0)HEXANE-3-CARBONITRILE, 2-((2S)-AMINO(3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)ACETYL), (1S,3S,5S)-; 2-Azabicyclo(3.1.0)hexane-3-carbonitrile, 2-((2S)-amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl) , (1S,3S,5S)-Sinónimos